Document Detail

Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein.
MedLine Citation:
PMID:  23208549     Owner:  NLM     Status:  Publisher    
Human lysyl-tRNA synthetase (hLysRS) is known to interact directly with human immunodeficiency virus type-1 (HIV-1) GagPol polyproteins, and both hLysRS with tRNA(Lys3) are selectively packaged into emerging HIV-1 viral particles. This packaging process appears to be mediated by contact between the motif 1 helix h7 of hLysRS and the C-terminal dimerization domain of the HIV-1 capsid protein (CA) segment of Gag or GagPol. Given similarities between hLysRS and Escherichia coli (E. coli) heat shock protein LysU, we investigate if LysU might be an hLysRS surrogate for interactions with Gag or GagPol proteins. We report on a series of studies involving three CA C-domains: CA(146) (intact domain), CA(151) (truncated domain), and CA(146)-M185A (M185A, CA dimer interface mutant). After confirming that LysU and CA(146) are dimeric whilst CA(151) and M185A remain monomeric, we use glutathione S-transferase (GST) pull-down assays to demonstrate the existence of specific interactions between LysU and all three CA-C domains. By means of (1)H-NMR titration experiments, we estimate K(d) values of 50 μM for the interaction between LysU and CA(146) or >500 μM for interactions between LysU and CA(151) or LysU and M185A. The reason for these binding affinity differences may be that interactions between LysU and CA(146) take place through dimer-dimer interactions resulting in a α(2)β(2) heterotetramer. LysU/CA-C protein interactions are weaker than those reported between hLysRS and the Gag, CA or CA(146) proteins, and hLysRS/Gag binding interactions have also been suggested to involve only αβ heterodimer formation. Nevertheless, we propose that LysU could act as a surrogate for hLysRS with respect to Gag and GagPol polyprotein interactions although arguably not sufficiently for LysU to act as an inhibitor of the HIV-1 life cycle without further adaptation or mutation. Potentially, LysU and/or LysU mutants could represent a new class of anti-HIV-1 therapeutic agent.
Nonlawat Boonyalai; James R Pullen; Mohd Firdaus Abdul Wahab; Michael Wright; Andrew D Miller
Related Documents :
15304769 - Enhanced expression of b-subunit of escherichia coli heat-labile enterotoxin in tobacco...
8938419 - Molecular characterization of potato fumarate hydratase and functional expression in es...
15221459 - A rab-related small gtp binding protein is predominantly expressed in root nodules of m...
24246999 - Expression of human achr extracellular domain mutants with improved characteristics.
19837869 - Yabbys and the transcriptional corepressors leunig and leunig_homolog maintain leaf pol...
16619029 - Role of sgt1 in resistance protein accumulation in plant immunity.
17900529 - Rnai of 14-3-3eta protein increases intracellular stability of tyrosine hydroxylase.
2584609 - Pilot scale production of a human monoclonal antibody against human immunodeficiency vi...
9014869 - Extraction and protein sequencing of immunoglobulin light chain from formalin-fixed cer...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  -     ISSN:  1477-0539     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Imperial College Genetic Therapies Centre, Department of Chemistry, Flowers Building, Armstrong Road, Imperial College London, London SW7 2AZ, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  How the Nucleus and Mitochondria Communicate in Energy Production During Stress: Nuclear MtATP6, an ...
Next Document:  Distinct roles for ?-arrestin2 and arrestin-domain-containing proteins in ?2 adrenergic receptor tra...